Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Dressing Designed to Prevent Skin Reactions During Radiation Therapy

By MedImaging International staff writers
Posted on 25 Feb 2014
New Zealand researchers have shown that severe skin reactions during radiotherapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment.

Although many skincare products have been assessed in clinical trials over the years, until now none has been able to completely prevent severe skin reactions, according to senior lecturer Dr. Patries Herst from the department of radiation therapy at the University of Otago Wellington (New Zealand). Dr. Herst and her team of radiation therapists, oncology nurses, and medical physicists have completed five randomized controlled clinical trials in New Zealand public hospitals in Dunedin, Wellington, Palmerston North, and Auckland Radiation Oncology over the past five years, all centering on side effects caused by radiation therapy.

Their most recent trial was a close collaboration with Dunedin Hospital, and demonstrated it is possible to prevent skin reactions from developing in breast cancer patients undergoing radiation therapy. Skin reactions are common in these patients, ranging from mild redness to ulceration with symptoms of pain, burning, and itchiness, Dr. Herst said. “This can impact negatively on day-to-day life for patients who already have to cope with being diagnosed with and treated for cancer.”

Dr. Herst is quite pleased with the results, and identification of a product that performs well. “This is fantastic news for cancer patients and it has put New Zealand firmly on the world map as a leader in clinical research into radiation-induced acute side effects.”

The dressings work by adhering closely to the small folds in the skin without the use of adhesives, so do not stick to open wounds. By protecting the radiation-damaged skin from friction against clothing items or other body regions, they allow the stem cells of the skin to heal from the radiation damage in an undisturbed setting. The dressings are also free of chemicals that could react with the skin.

Dr. Herst is currently setting up a trial that will evaluate the dressings in head and neck cancer patients. The study’s findings have been published online January 31, 2014, in the international journal Radiotherapy and Oncology.

Related Links:
University of Otago Wellington



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Compact C-Arm
Arcovis DRF-C S21
New
Breast Imaging Workstation
SecurView
Ultrasound Software
UltraExtend NX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.